4.82
-1.63%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Baotou Dongbao Bio-Tech Co
Its shares trade on Shenzhen under the ticker 300239.SZ. It has been listed since 6 July 2011. In the fiscal year to 31 December 2025, it reported revenue of CN¥745.3m and net income of CN¥54.3m. At that date it held total assets of CN¥2.55bn and shareholders' equity of CN¥1.72bn.
Baotou Dongbao Bio-Tech Co., Ltd. engages in the research and development, design, production, and sales of gelatin, collagen, and calcium hydrogen phosphate. The company is headquartered in Baotou, Neimenggu. The company went IPO on 2011-07-06. The firm primarily provides gelatin, which is used in the manufacture of empty capsules and food additives; calcium hydrophosphate, which is used in feed additives, as well as collagen series products, which are used in foods, cosmetics, health care products. The firm distributes its products in both domestic and overseas markets, with domestic markets as its major markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 6 Jul 2011
- Employees
- 1,356
- Website
- dongbaoshengwu.com ↗
Leadership
Pay as last reported
- Mr. Aiguo WangChairman of the Board, since 2021
- Mr. Haiqing HaoChief Financial Officer
- Mr. Fang LiuGeneral Manager, Director, since 2024CN¥328,300
- Ms. Huayi ShanDeputy General Manager, Secretary of the Board
- Mr. Yan LiuDeputy General Manager, Director, since 2021
- Mr. Furong WangDeputy General Manager, Director, since 2005
- Mr. Jianguang DuDeputy General Manager, since 2024
- Mr. E'erduntaoketao ..Independent Director
- Mr. Bin RenIndependent Director
- Mr. Jing WangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Baotou Dongbao Bio-Tech employs 1,356 full-time employees for efficient production and sales.
- The company focuses on gelatin, collagen, and calcium hydrogen phosphate for diverse applications.
- Domestic markets are the primary distribution channel for Baotou Dongbao Bio-Tech products.
Weaknesses
- The company's reliance on domestic markets limits international market expansion opportunities.
- Limited product range compared to competitors in the Chemicals sector.
- No mention of overseas market share or specific international partnerships.
Opportunities
- Growing demand for collagen in cosmetics and health care sectors globally.
- Expansion into overseas markets for calcium hydrophosphate feed additives.
- Increasing use of gelatin in food additives and empty capsules worldwide.
Threats
- Competition from other Chemicals sector companies in domestic markets.
- Potential regulatory changes affecting gelatin and collagen production.
- Economic downturns impacting the Materials sector demand.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.